Corcept Therapeutics Incorporated
NASDAQ:CORT · NASDAQ Capital Market
-$1.96 today
Vol 1.73M · Avg 1.41M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+7.58%
Period High
$90.32
Period Low
$32.15
Latest
$79.91
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Jazz Pharmaceuticals plc
NASDAQ:JAZZ
$14.26B
Axsome Therapeutics, Inc.
NASDAQ:AXSM
$12.98B
Cytokinetics, Incorporated
NASDAQ:CYTK
$9.72B
Nuvalent, Inc.
NASDAQ:NUVL
$9.07B
Halozyme Therapeutics, Inc.
NASDAQ:HALO
$8.13B
Merus N.V.
MRUS
$6.83B
Rhythm Pharmaceuticals, Inc.
NASDAQ:RYTM
$6.57B
Abivax S.A.
NASDAQ:ABVX
$6.57B
Caris Life Sciences, Inc.
NASDAQ:CAI
$5.05B
Atrium Therapeutics, Inc.
NASDAQ:RNA
$213.48M
What is the latest CORT filing?
The latest filing shown is 8-K dated Jun 17, 2026.
How many recent filings does CORT have?
Intrinsic Alpha currently shows 20 recent filings for CORT.
Explore More
Continue the stock analysis
Jump to another research area for this company.